Dr. David A. Dawson

Dr. David A. Dawson is a biomolecular psychologist and the founder of AMCANN Research, where he leads investigations into the quantitative characterization of the endocannabinoid system as a measurable component of human physiology.

His work focuses on developing analytical and diagnostic frameworks for evaluating endocannabinoid system function, with particular emphasis on biomarker identification, population-based reference modeling, and translational research. Integrating principles from molecular biology, psychopharmacology, and psychoneuroimmunology, his research is directed toward establishing clinically interpretable measures of endocannabinoid activity.

At AMCANN Research, Dr. Dawson oversees programs spanning endocannabinoid quantification, analytical method development, biomarker discovery, dysregulation modeling, and translational investigation. These initiatives are structured to support a continuous scientific pipeline in which laboratory measurements inform research frameworks and future diagnostic applications.

His broader objective is to advance the scientific understanding of the endocannabinoid system through rigorous measurement science and reproducible analytical methodologies, contributing to the development of objective biological frameworks comparable to those used in established endocrine and metabolic disciplines.